← FDA Drug Approvals (Drugs@FDA)

BEOVU

BLA · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2019-10-07

Drug application

FDA Application #

BLA761125

Application type

Biologics License Application

Brand name

BEOVU

Generic name

BROLUCIZUMAB

Active ingredients

brolucizumab-dbll

Dosage form

INJECTABLE

Route

INTRAVITREAL

Marketing status

Prescription

Sponsor

NOVARTIS PHARMS CORP

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2019-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown